Google
CODX Stock Analysis — CO-DIAGNOSTICS, INC. COMMON STOCK (Healthcare >> Medical Devices)
CODX FAQ
What is CODX's ROE?
CO-DIAGNOSTICS, INC. COMMON STOCK reports a Return on Equity (ROE) of -302.34%.
What is CODX's dividend yield?
CO-DIAGNOSTICS, INC. COMMON STOCK offers a dividend yield of 0.00%.
What is CODX's Quality Score?
Our AI rates CODX's overall financial quality at 23 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy CODX?
Our AI Timing Score for CODX is 26 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does CODX belong to?
CO-DIAGNOSTICS, INC. COMMON STOCK is classified under the Healthcare >> Medical Devices sector on the NASDAQ exchange
CODX AI Analysis Summary
Our AI summary for CODX: CO-DIAGNOSTICS, INC. COMMON STOCK (NASDAQ), Healthcare >> Medical Devices sector. The stock currently trades at a P/E of 0.00, ROE of -302.34%, a dividend yield of 0.00%. Its financial Quality Score stands at 23/100 — fundamentals below the market average. The AI Timing Score is 26/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 1.44
Price
-0.12
(-7.69%)
Day Change
|
|
|---|
CODX, the overall quality is not good ( Quality = 23) and the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROE is relatively low.
ROA is relatively low.
Historical ROE is relatively low
Negative growth of ROE in the last year.
ROE is decreasing significantly
ROA is too relatively low compare to ROE
Growth of ROA was below our criteria in the last year.
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Historical net profit margin is relatively low.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...
| Quality Factors |
|
48% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 92 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 1.44 |
| PBV / Sector |
0.36 / -101.57
GREAT
|
| Earning Per Share | -12.24 |
| PE / Sector |
N/A / 31.23
|
| PEG or PE/Growth / Sector |
N/A / 0.40
|
| Average 1M Daily Value |
0.61 M
GREAT
|
| Average 1W Daily Value |
1.16 M
GREAT
|
| Timing Factors |
|
14% |
| Financial Health |
|
45% |
| Ability to Make Profit |
|
56% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-08-01 07:59:39 |
| Symbol | CODX |
| Name | CO-DIAGNOSTICS, INC. COMMON STOCK |
| Sector | Healthcare >> Medical Devices |
| Market | NASDAQ |
| Listed Shares | 3.66 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 5.71 / 20,104.97 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 2401 S. Foothill Drive, Salt Lake City, UT, United States, 84109
Phone: 801 438 1036
Website: https://co-dx.com
Employees: 115
Sector: Healthcare >> Medical Devices
Description: Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. The company also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, malaria, dengue, human papillomavirus, chikungunya, and Zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. Co-Diagnostics, Inc. was incorporated in 2013 and is based in Salt Lake City, Utah.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Medical Devices
Click a bubble to view stock details · Bubble size represents market capitalization share
